Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27687878 | 1.00 | KMT2A (0.33) | KMT2AMEN1CYP3A4ALOX15HSD17B10 | |
| SCHEMBL18563063 | 0.80 | KMT2A (0.31) | KMT2A | |
| SCHEMBL8998672 | 0.79 | KMT2A (0.52) | KMT2AMEN1CYP3A4ALOX15HSD17B10 | |
| SCHEMBL29269857 | 0.79 | KMT2A (0.33) | KMT2AMEN1CYP3A4ALOX15HSD17B10 | |
| SCHEMBL8998681 | 0.79 | KMT2A (0.52) | KMT2AMEN1CYP3A4ALOX15HSD17B10 | |
| SCHEMBL14103976 | 0.77 | KMT2A (0.32) | KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL2122699 | 0.76 | — | — | |
| SCHEMBL2122698 | 0.76 | — | — | |
| SCHEMBL57059 | 0.75 | — | — | |
| SCHEMBL57058 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| EP-3319952-B1 | PROCESS FOR THE PRODUCTION OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL | NORAMCO INC (US) | 2020-02-05 | — | — | EP | disclosed |